Posted On: 06/23/2013 2:43:51 AM
Post# of 5066
Ok so here's my question.
Lets say all goes well and this product is a bonified cure for Aplastic Anemia..
It goes to market and saves lives
While being fine and dandy here comes the investor part.
1 in 25,000 people get this. Lets say 100% can afford, purchase and use this drug.
Aren't the numbers on that so low that BMSN will really not see as much revenue as we think?
Same question re worded in case that was confusing,
If only 1 in 25,000 need and purchase this product how much revenue is that really? I mean that's if 100% of those diagnosed are able to purchase said drug.
Does that make sense?
Lets say all goes well and this product is a bonified cure for Aplastic Anemia..
It goes to market and saves lives
While being fine and dandy here comes the investor part.
1 in 25,000 people get this. Lets say 100% can afford, purchase and use this drug.
Aren't the numbers on that so low that BMSN will really not see as much revenue as we think?
Same question re worded in case that was confusing,
If only 1 in 25,000 need and purchase this product how much revenue is that really? I mean that's if 100% of those diagnosed are able to purchase said drug.
Does that make sense?
(0)
(0)
